Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 4 | 2023 | 2788 | 1.210 |
Why?
|
| Pulmonary Veins | 2 | 2023 | 757 | 0.990 |
Why?
|
| Bundle of His | 1 | 2022 | 102 | 0.760 |
Why?
|
| Atrial Flutter | 1 | 2022 | 253 | 0.670 |
Why?
|
| Heart Conduction System | 2 | 2020 | 1006 | 0.550 |
Why?
|
| Cryosurgery | 1 | 2022 | 479 | 0.550 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 463 | 0.540 |
Why?
|
| Atrial Appendage | 1 | 2020 | 284 | 0.520 |
Why?
|
| Electric Stimulation Therapy | 1 | 2022 | 635 | 0.510 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2022 | 2247 | 0.440 |
Why?
|
| Tachycardia, Ventricular | 1 | 2022 | 1310 | 0.440 |
Why?
|
| Atrial Fibrillation | 6 | 2023 | 5189 | 0.410 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2018 | 562 | 0.410 |
Why?
|
| Accidental Falls | 2 | 2010 | 1078 | 0.390 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 845 | 0.350 |
Why?
|
| Amino Acids | 1 | 2016 | 1709 | 0.350 |
Why?
|
| Friedreich Ataxia | 1 | 2010 | 82 | 0.320 |
Why?
|
| Health Services for the Aged | 1 | 2010 | 265 | 0.300 |
Why?
|
| Physical Endurance | 3 | 2017 | 368 | 0.260 |
Why?
|
| Community Health Services | 1 | 2010 | 657 | 0.250 |
Why?
|
| Heart Rate | 3 | 2023 | 4204 | 0.250 |
Why?
|
| Running | 2 | 2017 | 488 | 0.190 |
Why?
|
| Hip Fractures | 1 | 2009 | 997 | 0.180 |
Why?
|
| Program Evaluation | 1 | 2009 | 2499 | 0.180 |
Why?
|
| Electrodes | 1 | 2022 | 609 | 0.170 |
Why?
|
| Ireland | 2 | 2010 | 170 | 0.170 |
Why?
|
| Atrial Function, Left | 1 | 2020 | 189 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 2136 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2022 | 422 | 0.160 |
Why?
|
| Heart Failure | 3 | 2018 | 11840 | 0.150 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 2511 | 0.150 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2022 | 881 | 0.140 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2018 | 122 | 0.140 |
Why?
|
| Health Promotion | 1 | 2009 | 2208 | 0.140 |
Why?
|
| Coronary Stenosis | 2 | 2013 | 800 | 0.140 |
Why?
|
| Heart Atria | 2 | 2020 | 1363 | 0.140 |
Why?
|
| GATA6 Transcription Factor | 1 | 2016 | 53 | 0.130 |
Why?
|
| Ethanol | 1 | 2022 | 1323 | 0.130 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 830 | 0.130 |
Why?
|
| Device Removal | 1 | 2021 | 646 | 0.130 |
Why?
|
| Action Potentials | 2 | 2020 | 1838 | 0.130 |
Why?
|
| Adenine | 1 | 2020 | 994 | 0.120 |
Why?
|
| Electrocardiography | 2 | 2018 | 6404 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2023 | 2428 | 0.110 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2016 | 477 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2016 | 452 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2017 | 547 | 0.110 |
Why?
|
| Swine | 1 | 2022 | 5988 | 0.100 |
Why?
|
| Pedigree | 2 | 2016 | 4526 | 0.100 |
Why?
|
| Piperidines | 1 | 2020 | 1664 | 0.100 |
Why?
|
| Recurrence | 1 | 2023 | 8501 | 0.090 |
Why?
|
| Social Marketing | 1 | 2009 | 51 | 0.080 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2013 | 345 | 0.080 |
Why?
|
| Athletes | 1 | 2017 | 1162 | 0.080 |
Why?
|
| Humans | 23 | 2023 | 765968 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1402 | 0.080 |
Why?
|
| Heart Ventricles | 2 | 2018 | 3832 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2016 | 1568 | 0.080 |
Why?
|
| Gastroenteritis | 1 | 2010 | 229 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4108 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1587 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2023 | 65188 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2017 | 2747 | 0.060 |
Why?
|
| Germany | 2 | 2017 | 882 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3655 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5696 | 0.060 |
Why?
|
| Male | 14 | 2021 | 363698 | 0.060 |
Why?
|
| Heart | 1 | 2017 | 4414 | 0.050 |
Why?
|
| DNA | 1 | 2016 | 7202 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2018 | 6610 | 0.050 |
Why?
|
| Macrophages | 1 | 2017 | 5772 | 0.050 |
Why?
|
| Genotype | 1 | 2016 | 13024 | 0.050 |
Why?
|
| Phenotype | 2 | 2017 | 16721 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2011 | 1799 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 310 | 0.050 |
Why?
|
| Myocytes, Cardiac | 2 | 2023 | 1668 | 0.050 |
Why?
|
| Beverages | 2 | 2017 | 819 | 0.050 |
Why?
|
| Stents | 1 | 2013 | 3213 | 0.050 |
Why?
|
| Time Factors | 5 | 2017 | 40065 | 0.040 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 2932 | 0.040 |
Why?
|
| Exercise | 1 | 2017 | 5937 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2009 | 1582 | 0.040 |
Why?
|
| Female | 11 | 2021 | 396112 | 0.040 |
Why?
|
| Mice, Inbred CBA | 1 | 2020 | 439 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3785 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 369 | 0.040 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 2593 | 0.040 |
Why?
|
| Adult | 8 | 2020 | 223044 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13648 | 0.040 |
Why?
|
| Risk Factors | 5 | 2020 | 74840 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8086 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 2495 | 0.040 |
Why?
|
| Middle Aged | 11 | 2021 | 223009 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 168764 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5526 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2009 | 2041 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 16047 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 59489 | 0.030 |
Why?
|
| Lasers | 1 | 2021 | 951 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 54802 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 18380 | 0.030 |
Why?
|
| Connexin 43 | 1 | 2017 | 202 | 0.030 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2017 | 169 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2010 | 5596 | 0.030 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2016 | 202 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 2021 | 827 | 0.030 |
Why?
|
| Aged | 6 | 2018 | 171117 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
| Hemolysis | 1 | 2016 | 406 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1751 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8923 | 0.030 |
Why?
|
| Equipment Design | 1 | 2021 | 3481 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 2021 | 1490 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2017 | 718 | 0.020 |
Why?
|
| Troponin T | 1 | 2016 | 785 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22332 | 0.020 |
Why?
|
| Coronary Restenosis | 1 | 2013 | 396 | 0.020 |
Why?
|
| Calcium | 1 | 2023 | 5767 | 0.020 |
Why?
|
| Genes, erbB-2 | 1 | 2010 | 160 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2018 | 2140 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2601 | 0.020 |
Why?
|
| Age of Onset | 1 | 2016 | 3344 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2017 | 4015 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2010 | 698 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14448 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 24282 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3432 | 0.010 |
Why?
|
| Young Adult | 3 | 2017 | 59889 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2505 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2023 | 12131 | 0.010 |
Why?
|
| Massachusetts | 1 | 2016 | 8875 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81819 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 5045 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2017 | 12437 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21056 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6203 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 6832 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2013 | 3096 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6499 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4493 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12056 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2011 | 9649 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12807 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10070 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14652 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2011 | 41649 | 0.010 |
Why?
|
| Sex Factors | 1 | 2011 | 10603 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15398 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12795 | 0.010 |
Why?
|
| Registries | 1 | 2013 | 8297 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12509 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 11022 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13266 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15880 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 15842 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9249 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81514 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11499 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30198 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14071 | 0.010 |
Why?
|
| United States | 1 | 2011 | 72903 | 0.000 |
Why?
|
| Adolescent | 1 | 2011 | 88835 | 0.000 |
Why?
|
Concepts
(162)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_